Abstract
The binding of fisetin with human serum albumin (HSA) has been studied at different pH using UV-Vis, FTIR, CD and fluorescence spectroscopic techniques. The binding constants were found to increase with the rise in pH of the media. The negative ΔH° (kJ mol-1) and positive ΔS° (J mol-1 K-1) indicate that fisetin binds to HSA via electrostatic interactions with an initial hydrophobic association that result in a positive ΔS°. In presence of potassium chloride (KCl) the binding constants were found to be decrease. The α-helical content of HSA increased after binding with fisetin as analyzed from both CD and FTIR methods. The site marker displacement studies using fluorescence anisotropy suggest that fisetin binds to the hydrophobic pocket (Site 1, subdomain IIA) of HSA which is in good accordance with the molecular docking study. The change in accessible surface area (ASA) of residues of HSA was calculated to get a better insight into the binding.
Keywords: Binding, docking, fisetin, fluorescence and human serum albumin, antioxidant agents, ischemia, atherosclerosis, cardiovascular disease, human mast cells (HMC-1)
Protein & Peptide Letters
Title:Study of the Interaction Between Fisetin and Human Serum Albumin: A Biophysical Approach
Volume: 19 Issue: 6
Author(s): Atanu Singha Roy, Amit Kumar Dinda and Swagata Dasgupta
Affiliation:
Keywords: Binding, docking, fisetin, fluorescence and human serum albumin, antioxidant agents, ischemia, atherosclerosis, cardiovascular disease, human mast cells (HMC-1)
Abstract: The binding of fisetin with human serum albumin (HSA) has been studied at different pH using UV-Vis, FTIR, CD and fluorescence spectroscopic techniques. The binding constants were found to increase with the rise in pH of the media. The negative ΔH° (kJ mol-1) and positive ΔS° (J mol-1 K-1) indicate that fisetin binds to HSA via electrostatic interactions with an initial hydrophobic association that result in a positive ΔS°. In presence of potassium chloride (KCl) the binding constants were found to be decrease. The α-helical content of HSA increased after binding with fisetin as analyzed from both CD and FTIR methods. The site marker displacement studies using fluorescence anisotropy suggest that fisetin binds to the hydrophobic pocket (Site 1, subdomain IIA) of HSA which is in good accordance with the molecular docking study. The change in accessible surface area (ASA) of residues of HSA was calculated to get a better insight into the binding.
Export Options
About this article
Cite this article as:
Singha Roy Atanu, Kumar Dinda Amit and Dasgupta Swagata, Study of the Interaction Between Fisetin and Human Serum Albumin: A Biophysical Approach, Protein & Peptide Letters 2012; 19 (6) . https://dx.doi.org/10.2174/092986612800493995
DOI https://dx.doi.org/10.2174/092986612800493995 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Activity of Cardiovascular Agents from Herbal Medicine
Cardiovascular & Hematological Agents in Medicinal Chemistry Recognition of Nucleic Acids by Toll-Like Receptors and Development of Immunomodulatory Drugs
Current Medicinal Chemistry Patent Selections
Recent Patents on Chemical Engineering Safety and Efficacy of Dexamethasone Intravitreal Implant (Ozurdex) for the Treatment of Persistent Macular Edema Secondary to Retinal Vein Occlusion in Eyes Previously Treated with Anti-Vascular Endothelial Growth Factors
Current Drug Safety Role of Type I Cytokines in Host Defense Against Mycobacterium avium Infection
Current Pharmaceutical Design Thyroid: Iodine Beyond the Thyronines
Current Chemical Biology RING Finger E3 Ubiquitin Ligases: Structure and Drug Discovery
Current Pharmaceutical Design Future Therapeutic Strategies in Inflammatory Cardiomyopathy: Insights from the Experimental Autoimmune Myocarditis Model
Cardiovascular & Hematological Disorders-Drug Targets Vascular Patency: A Biomarker and Clinical Target Quantified with High Resolution MRI and Novel Cellular Pathways
Current Neurovascular Research Novel Agents Targeting Nitric Oxide
Current Vascular Pharmacology New Vascular Disrupting Agents in Upper Gastrointestinal Malignancies
Current Medicinal Chemistry Meet Our Editor
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Chiral Kinase Inhibitors
Current Topics in Medicinal Chemistry Protein-Protein Interaction Inhibitors: Small Molecules from Screening Techniques
Current Topics in Medicinal Chemistry Herpes Simplex Virus Type 1 Amplicons and their Hybrid Virus Partners, EBV, AAV, and Retrovirus
Current Gene Therapy Gene Therapy for Gastric Diseases
Current Gene Therapy Drug Repositioning: A Smart Approach for Combating SARS-CoV-2
Anti-Infective Agents Foreword
Recent Patents on CNS Drug Discovery (Discontinued) Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies
Current Pharmaceutical Design Role of Dendrimer in Drug Solubilization - A Review
Drug Delivery Letters